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poisoningAbstract Extracorporeal Membrane Oxygenation (ECMO) is emergently used for long-term sup-
port of respiratory and/or cardiac functions. ECMO is most useful in cases when the primary lung
insult is reversible. CESAR trial in 2009 showed survival benefits in severe ARDS patients when
transferred to an ECMO center compared to those receiving standard care in their ICU.
Organophosphate (OP) compounds are large groups of chemicals used in domestic and industrial
settings. These compounds are still used in different forms in developing countries. It can affect the
respiratory system through causing: rhinorrhea, bronchorrhea, bronchospasm, cough and severe
respiratory distress. Respiratory failure is the most life threatening condition and requires immedi-
ate intervention.
We present a case report of OP induced severe ARDS in which conventional lung protective ven-
tilation failed to maintain adequate oxygenation that was accomplished by ECMO.
 2016 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Extracorporeal Membrane Oxygenation (ECMO) is used for
respiratory function support. It is indicated for patients with
severe ventilation and/or oxygenation failure who are unlikely
to survive conventional lung protective mechanical ventilation
[1,2]. ECMO is most useful when the primary lung insult is
thought to be reversible [3].
Organophosphate (OP) compounds are diverse groups of
chemicals used in both domestic and industrial settings [4].
These compounds are still used in different forms in develop-
ing countries in domestic uses [4]. It can affect respiratory
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chospasm, cough, and severe respiratory distress. Respiratory
failure and adult respiratory distress syndrome (ARDS) are the
most life-threatening sequelae and require immediate interven-
tion [5,6].
We here discuss a case report of a patient presented to our
center after accidental ingestion of one of these compounds
leading to development of severe ARDS.2. Case report
A 14 year old female patient, actual body weight 50 kg with no
relevant past medical history, presented to KasrEl-Ainy Toxi-
cology Center, Cairo university, with a history of accidental
ingestion of an organophosphorus compound (Chlorpyrifos).
Routine management was initiated there in the form of general
supportive measures, atropine and neostigmine. Two days
after admission she complained of increasing respiratory dis-
tress coinciding with progressive hypoxemia and the appear-
ance of bilateral lung infiltrates on CXR and CT chest (Fig. 1).
She was invasively ventilated on lung protective strategy
using low tidal volume of 6 ml/kg, PEEP of 14 cm H2O and
an FiO2 of 1, on an assisted volume control mode. She had
an event of cardiac arrest in bradycardia that happened with
progressive unresponsive hypoxia with successful resuscitation.
She was transferred to our center for the possibility of
ECMO. When admitted she was sedated with propofol
0.05 mg/kg/min, paralyzed with atracurium 10 mcg/kg/min
and maintained on vasopressors noradrenalin 0.1 lg/kg/min
with her hemodynamic profile showing blood pressure
132/83 mmHg, heart rate 135 beat/min, temperature 36.8 C
and central venous pressure 8 cm H2O. With sedation vaca-
tion, she regained consciousness after the cardiac arrest event.Figure 1 CT scan showing diffArterial blood gases showed pH 7.29, PCO2 55 mmHg, PO2
55 mmHg, HCO3 26 mEq/L and O2 Saturation of 75%. Prone
positioning was tried with no improvement in oxygenation.
Murray Lung Injury Score was 3.25, PaO2/FIO2 ratio was
55, 3 quadrants affected in CXR, PEEP of 14 cm H2O and
lung compliance was 23 ml/cm H2O.
Laboratory profile showed normal serum electrolytes and
renal function. She was severely anemic with a hemoglobin
level of 6.8 gm/dl, for which three units of packed RBCs were
given. Cholinesterase level was almost not detected supporting
the diagnosis of OP poisoning, H1N1 screen was negative, spu-
tum and blood culture that yielded no growth.
Decisions were taken to initiate veno-venous (V-V) ECMO
after taking the father’s consent. Percutaneous cannulation
was done via femoro-atrial approach using drainage right
femoral Maquet cannula (23 f/38 cm) and return right internal
jugular Maquet cannula (21 f/23 cm) and the cannula positions
were verified with CXR and ultrasonography (Fig. 2). Rota-
flow console from Maquet was used.
The patient RESP score [7] was 0 correlating with a survival
of 40–60%. The flow during the first 24 h ranged from 80 to
100 ml/kg/min. Mechanical ventilation during ECMO was on
assisted pressure controlled ventilation with peak inspiratory
pressure of 15 cm H2O, PEEP 10 cm H2O and FiO2 40%
resulting in a tidal volume of 60–80 ml.
Anticoagulation using unfractionated heparin infusion was
initiated, target a Partial Thromboplastin time (PTT) of 50–
60 ms.
The ECMO run duration was 6 days. On day 5 there was
dramatic improvement in oxygenation PaO2/FIO2 reached
250, lung compliance 55 ml/cm H2O and that was coinciding
with significant improvement of CXR (Fig. 3a and b).
Successful decannulation was done after weaning from
ECMO on day 6 by decreasing FiO2 on ECMO while contin-use bilateral lung infiltrates.
Figure 2 CXR showing both cannulae inserted on day 1.
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was done after 2 days of ECMO decannulation.
The patient suffered from difficulty in swallowing as a
residual nicotinic effect of OP poisoning that improved over
several days. Mood changes and post-traumatic stress disorder
were other consequences that were followed up on outpatient
basis with neuro-psychiatry consultants.
3. Discussion
This is a case fulfilling the criteria of severe ARDS after OP
poisoning. Diagnosis of OP poisoning was done by history
of ingestion, and confirmed with cholinesterase level and
absence of causative organism in cultures.
Organophosphorus poisoning is a very common problem in
developing countries and is a major problem in south west
Asia specially India. There are several case reports and papers
that discussed this problem [8–10]. The main treatment is atro-Figure 3 (a) Showing CXR after lung imppine in large doses to compete with acetylcholine on mus-
carinic acetylcholine receptors thus decreasing the cholinergic
crisis manifestations. In our case the patient presented to the
toxicology hospital in respiratory arrest, she was successfully
resuscitated and atropine was given repeatedly until dilatation
of her pupils. The mechanism of ARDS in organophosphorus
poisoning may be attributed to be a complication of aspiration
and super added acquired infection. We believe aspiration and
consequent ARDS were the scenario in our patient. Lainee
et al. animal studies showed that intravenous injection of
organophosphorus compounds in dogs initiated ARDS
through breakdown of alveolar/endothelial barrier and inflam-
matory/exudative infiltrates into the lungs within two hours
[11,12]. These cases could benefit from V-V ECMO support
according to the ELSO guidelines especially in the presence
of a totally reversible cause as OP poisoning. Mechanical ven-
tilation less than 7 days before ECMO carries a favorable out-
come [13,14]. There are many case reports about OP induced
respiratory failure that required mechanical ventilation as a
solution for respiratory failure but no cases with ECMO was
shown to be published to our knowledge. Mechanical ventila-
tion was initiated in our case before ECMO for respiratory
support but it failed to maintain adequate oxygenation.
In previous ECMO studies and similarly in our case V-V
femoro-jugular percutaneous cannulation approach was
shown to be better than other approaches since less pump flow
is needed to achieve the same oxygenation [15].
Weaning from V-V ECMO in our case is done through
keeping same flow to avoid oxygenator thrombosis followed
by decreasing ECMO FIO2 over 24 h then decannulation if
we have satisfactory blood gases on low requirement mechan-
ical ventilation [16].
As regards the neurological, post-traumatic stress disorder
and depression are common in survivors of ARDS a condition
which may persist for years as mentioned in the study by
Kapfhammer et al. in 2004 [17].4. Conclusion
ECMO can be successfully used in treatment of ARDS, espe-
cially, when due to reversible causes as OP poisoning.rovement and (b) after decannulation.
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